1. Li, Q, Guan, X, Wu, P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382: 1199–1207.
Google Scholar | Crossref | Medline2. Wu, Y, Ho, W, Huang, Y, et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet 2020; 395: 949–950.
Google Scholar | Crossref | Medline3. Zhu, N, Zhang, D, Wang, W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382: 727–733.
Google Scholar | Crossref | Medline4. Sohrabi, C, Alsafi, Z, O’Neill, N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71–76.
Google Scholar | Crossref | Medline5. Jiang, F, Deng, L, Zhang, L, et al. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med 2020; 35: 1545–1549.
Google Scholar | Crossref | Medline6. Lauer, SA, Grantz, KH, Bi, Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 2020; 172: 577–582.
Google Scholar | Crossref | Medline7. Bouadma, L, Lescure, F-X, Lucet, J-C, et al. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med 2020; 46: 579–582.
Google Scholar | Crossref | Medline8. Yang, X, Yu, Y, Xu, J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8: 475–481.
Google Scholar | Crossref | Medline9. Arentz, M, Yim, E, Klaff, L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020; 323: 1612–1614.
Google Scholar | Crossref | Medline10. Grasselli, G, Zangrillo, A, Zanella, A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; 323: 1574–1581.
Google Scholar | Crossref | Medline11. Wang, K, Zhao, W, Li, J, et al. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China. Ann Intensive Care 2020; 10: 37.
Google Scholar | Crossref | Medline12. Frat, J-P, Thille, AW, Mercat, A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372: 2185–2196.
Google Scholar | Crossref | Medline | ISI13. Messika, J, Ben Ahmed, K, Gaudry, S, et al. Use of high-flow nasal cannula oxygen therapy in subjects with ARDS: a 1-year observational study. Respir Care 2015; 60: 162–169.
Google Scholar | Crossref | Medline | ISI14. Ni, Y-N, Luo, J, Yu, H, et al. The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis. Am J Emerg Med 2018; 36: 226–233.
Google Scholar | Crossref | Medline15. Rochwerg, B, Granton, D, Wang, DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med 2019; 45: 563–572.
Google Scholar | Crossref | Medline16. Hui, DS, Chow, BK, Lo, T, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 2019; 53: 1802339.
Google Scholar | Crossref | Medline17. Fuchs, A, Lanzi, D, Beilstein, CM, et al. Clinical recommendations for in-hospital airway management during aerosol-transmitting procedures in the setting of a viral pandemic. Best Pract Res Clin Anaesthesiol. Epub ahead of print 8 December 2020. DOI: 10.1016/j.bpa.2020.12.002
Google Scholar | Crossref18. Li, J, Fink, JB, Ehrmann, S. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J 2020; 55: 2000892.
Google Scholar | Crossref | Medline19. Li, J, Fink, JB, Elshafei, AA, et al. Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion. ERJ Open Res 2021; 7: 00519–2020.
Google Scholar | Crossref | Medline20. Jermy, MC, Spence, CJT, Kirton, R, et al. Assessment of dispersion of airborne particles of oral/nasal fluid by high flow nasal cannula therapy. PLoS One 2021; 16: e0246123.
Google Scholar | Crossref | Medline21. Elshof, J, Hebbink, RHJ, Duiverman, ML, et al. High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion. Eur Respir J 2020; 56: 2003004.
Google Scholar | Crossref | Medline22. Gattinoni, L, Coppola, S, Cressoni, M, et al. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med 2020; 201: 1299–1300.
Google Scholar | Crossref | Medline23. Darmon, M, Constantin, JM, Guéry, B. Recommandations d’experts portant sur la prise en charge en réanimation des patients en période d’épidémie à SARS-CoV2. SRLF SFAR SFMU GFRUP SPILF SPLF recommendations. https://sfar.org/download/recommandations-dexperts-portant-sur-la-prise-en-charge-en-reanimation-des-patients-en-periode-depidemie-a-sars-cov2/?wpdmdl=25387&refresh=60ab604d8eae11621844045 (2020, accessed 15 March 2020).
Google Scholar24. Alhazzani, W, Møller, MH, Arabi, YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 2020; 48: e440–e469.
Google Scholar25. ARDS Definition Task Force , Ranieri, VM, Rubenfeld, GD, Thompson, BT, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012; 307: 2526–2533.
Google Scholar | Medline | ISI26. Vincent, JL, Moreno, R, Takala, J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707–710.
Google Scholar | Crossref | Medline | ISI27. Knaus, WA, Draper, EA, Wagner, DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–829.
Google Scholar | Crossref | Medline | ISI28. Delorme, M, Bouchard, PA, Simon, M, et al. Effects of high-flow nasal cannula on the work of breathing in patients recovering from acute respiratory failure. Crit Care Med 2017; 45: 1981–1988.
Google Scholar | Crossref | Medline29. Auld, SC, Caridi-Scheible, M, Blum, JM, et al. ICU and ventilator mortality among critically ill adults with coronavirus disease 2019. Crit Care Med 2020; 48: e799–e804.
Google Scholar30. Agarwal, A, Basmaji, J, Muttalib, F, et al. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth 2020; 67: 1217–1248.
Google Scholar | Crossref | Medline31. Bellani, G, Laffey, JG, Pham, T, et al., For the LUNG SAFE Investigators and the ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016; 315: 788.
Google Scholar32. Darreau, C, Martino, F, Saint-Martin, M, et al. Use, timing and factors associated with tracheal intubation in septic shock: a prospective multicentric observational study. Ann Intensive Care 2020; 10: 62.
Google Scholar | Crossref | Medline33. Kang, BJ, Koh, Y, Lim, C-M, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med 2015; 41: 623–632.
Google Scholar | Crossref | Medline | ISI34. Koyauchi, T, Hasegawa, H, Kanata, K, et al. Efficacy and tolerability of high-flow nasal cannula oxygen therapy for hypoxemic respiratory failure in patients with interstitial lung disease with do-not-intubate orders: a retrospective single-center study. Respiration 2018; 96: 323–329.
Google Scholar | Crossref | Medline35. Leung, CCH, Joynt, GM, Gomersall, CD, et al. Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. J Hosp Infect 2019; 101: 84–87.
Google Scholar | Crossref | Medline